Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia

- Degryse, S., De Bock, C. E., Verrills, N. M., Van Vlierberghe, P., Cools, J., Dun, M. D., Demeyer, S., Govaerts, I., Bornschein, S., Verbeke, D., Jacobs, K., Binos, S., Skerrett-Byrne, D. A., Murray, H. C.

Targeting PP2A and proteasome activity ameliorates features of allergic airway disease in mice

- Nair, P. M., Starkey, M. R., Haw, T. J., Liu, G., Horvat, J. C., Morris, J. C., Verrills, N. M., Clark, A. R., Ammit, A. J., Hansbro, P. M.

Treatment of inflammatory arthritis via targeting of tristetraprolin, a master regulator of pro-inflammatory gene expression

- Ross, E. A., Naylor, A. J., Dominguez, S., Perlman, H., Verrills, N. M., Kollias, G., Vitek, M. P., Filer, A., Buckley, C. D., Dean, J. L., Clark, A. R., O'Neil, J. D., Crowley, T., Ridley, M. L., Crowe, J., Smallie, T., Tang, T. J., Turner, J. D., Norling, L. V.

PR55α-containing protein phosphatase 2A complexes promote cancer cell migration and invasion through regulation of AP-1 transcriptional activity

- Gilan, O., Diesch, J., Dhillon, A. S., Amalia, M., Jastrzebski, K., Chueh, A. C., Verrills, N. M., Pearson, R. B., Mariadason, J. M., Tulchinsky, E., Hannan, R. D.

Suppression of PP2A is critical for protection of melanoma cells upon endoplasmic reticulum stress

- Tay, K. H., Jin, L., Zhang, X. D., Tseng, H. - Y., Jiang, C. C., Ye, Y., Thorne, R. F., Liu, T., Guo, S. T., Verrills, N. M., Hersey, P.